-
News | 2022.12.01
Institut Pasteur at the 2022 Utopiales international science fiction festival in Nantes
For the second year in a row, the Institut Pasteur was one of the official scientific partners of the Utopiales festival, which took place from October 29 to November 1 at La Cité Nantes Congress Center.
-
Document de presse | 2023.12.06
Plasmodium vivax malaria: infections may be largely underestimated in sub-Saharan Africa
Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University Hospital, in collaboration with King's College London, UK, the Institut Pasteur (Paris, France), the Institut Pasteur de Madagascar and the University of Addis Ababa, Ethiopia, have revealed how...
-
News | 2024.03.19
Pasteur Museum: transferring the collections to protect them
As part of the work to restore and renovate the Institut Pasteur's historical building, the Pasteur Museum recently embarked on an unprecedented process to transfer its collections. This involves meticulously preparing the items so that they can be stored in dedicated spaces that are suitable for housing such valuable objects.
-
News | 2023.05.12
A new approach to developing mouse 'embryos' in vitro
The study of embryonic development is a complex and tightly regulated field. By influencing a process that regulates gene expression, researchers at the Institut Pasteur have succeeded in recreating in vitro mouse cell clusters that mimic in some respects the structure of real embryos. By avoiding the manipulation of embryos, these approaches pave the way for applications such as the study of...
-
Fiche maladie | 2024.08.23
Stomach cancer and gastric ulcers
The bacterium Helicobacter pylori (H. Pylori) is the causative agent of stomach diseases in humans, including chronic gastritis, gastric ulcers (open sores that develop on the mucosa lining the stomach) and duodenal ulcers. It also plays a major role in stomach cancer genesis (adenocarcinoma and lymphoma). These findings have led to a review of treatment for peptic ulcer disease which is now...
-
Article | 2020.08.13
The Institut Pasteur Innovation Accelerator
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
-
News | 2025.08.27
Discover the Pasteur Institute's major discoveries for 2024
A gene therapy trial for childhood deafness. A malaria vaccine. Microbiome gene editing. Cancer immunotherapy. A key gene in embryonic development. Effective treatment for bronchiolitis. Indian Ocean temperatures for anticipating outbreaks... Here is an excerpt from our discoveries for 2024. You can also download the poster in PDF format at the bottom of the page.
-
Document de presse | 2016.03.07
Obesity: an epigenetic track to fight against weight gain and hypercholesterolemia
The number of obesity cases has doubled since 1980: in 2014, over 600 million adults were affected across the world. The causes of this epidemic include unbalanced diet, as well as environmental and genetic factors. French INRA researchers, in association with colleagues from the Institut Pasteur, Inserm, CNRS and the University of Cambridge (UK), reveal that an epigenetic factor, the BAHD1...
-
Document de presse | 2014.12.03
Institut Pasteur Graduation Ceremony 2014
The Institut Pasteur will host on the 12th of December 2014 the 2nd ceremony in honor of its graduating PhD class, with the Doctors having defended in 2013-2014. This ceremony will be chaired by Pr Christian Bréchot, President of the Institut Pasteur. It will be held in presence of Jean-Philippe Pierre, deputy mayor of the 15th arrondissement of Paris. Press release Paris,...
-
Document de presse | 2010.02.14
Customized stem cells to help treat leukemia?
Researchers at the Institut Pasteur and the French National Center for Scientific Research (CNRS) have just discovered the origin of hematopoietic stem cells (HSC), which give rise to all blood and immune cells in the body. Using real-time imaging technology on zebrafish embryos, the researchers observed that these stem cells were formed from the cells of the aortic wall, the embryo's main...